Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
13 10 Search
2025
MicroRNA biomarkers in cerebrospinal fluid and plasma predicting cognitive decline in Alzheimer's disease
Journal of Alzheimer’s Disease
2024
The molecular mechanism of MiR-26a-5p regulates autophagy and activates NLRP3 inflammasome to mediate cardiomyocyte hypertrophy
BMC Cardiovascular Disorders
2024
Epigenetic signatures in cardiac fibrosis: Focusing on noncoding RNA regulators as the gatekeepers of cardiac fibroblast identity
International Journal of Biological Macromolecules
2024
miR-26a is a Key Therapeutic Target with Enormous Potential in the Diagnosis and Prognosis of Human Disease
Current Medicinal Chemistry
2023
Extracellular vesicles and Duchenne muscular dystrophy pathology: Modulators of disease progression
Frontiers in Physiology
2023
MiR-423-5p Inhibition Exerts Protective Effects on Angiotensin II-Induced Cardiomyocyte Hypertrophy
The Tohoku Journal of Experimental Medicine
2022
Long-term culture of patient-derived cardiac organoids recapitulated Duchenne muscular dystrophy cardiomyopathy and disease progression
Frontiers in Cell and Developmental Biology
2021
MicroRNA-26a/b-5p promotes myocardial infarction-induced cell death by downregulating cytochrome c oxidase 5a
Experimental & Molecular Medicine
2021
Analysis of metabolomic and genomic markers for diagnosing cardiovascular diseases
Medical academic journal
2021
RNA binding Motif protein-38 regulates myocardial hypertrophy in LXR-α-dependent lipogenesis pathway
Bioengineered
2021
WITHDRAWN: MiR-140 suppresses airway inflammation and inhibits bronchial epithelial cell apoptosis in asthma by targeting GSK3β
Experimental and Molecular Pathology
Additional cited-by details will be shown when available from Crossref